Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Boston Scientific Gains Chinese Approval to Market Asthma Remedy

With the rate of those suffering from asthma in China growing dramatically -- many point to China's well-documented pollution problems as a key contributing factor -- Boston Scientific (NYSE: BSX  ) announced today that it has gained approval from the China Food and Drug Administration for its Alair Bronchial Thermoplasty System.

The U.S. FDA first approved the Alair system in 2010, when it was submitted for review by Asthmatx, a company Boston Scientific acquired later that same year for $193.5 million, plus additional payments of as much as $250 million based on meeting certain sales objectives.

Bronchial Thermoplasty, according to Boston Scientific, is an outpatient treatment that uses mild heat to help reduce the constriction of the airways asthma sufferers contend with.

"We believe this device can markedly improve the quality of life of asthma patients here in China," said Warren Wang, Boston Scientific vice president and managing director, China.

Asthma has steadily increased in China the past 20 years, according to numerous reports, and some estimates suggest the rates of asthma are up as much as 40% in the past five years alone.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2696107, ~/Articles/ArticleHandler.aspx, 9/28/2016 11:46:04 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 hour ago Sponsored by:
DOW 18,339.24 110.94 0.61%
S&P 500 2,171.37 11.44 0.53%
NASD 5,318.55 12.84 0.24%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/28/2016 4:02 PM
BSX $23.75 Up +0.03 +0.13%
Boston Scientific CAPS Rating: ***